Journal
PHARMACEUTICALS
Volume 8, Issue 4, Pages 848-864Publisher
MDPI
DOI: 10.3390/ph8040848
Keywords
angiogenesis; cancer; coagulation; inflammation; marine glycans; microbial infection; sulfated fucans; sulfated galactans; thrombosis
Categories
Ask authors/readers for more resources
Sulfated fucans (SFs) and sulfated galactans (SGs) are currently the marine non-glycosaminoglycan (GAG) sulfated glycans most studied in glycomics. These compounds exhibit therapeutic effects in several pathophysiological systems such as blood coagulation, thrombosis, neovascularization, cancer, inflammation, and microbial infections. As analogs of the largely employed GAGs and due to some limitations of the GAG-based therapies, SFs and SGs comprise new carbohydrate-based therapeutics available for clinical studies. Here, the principal structural features and the major mechanisms of action of the SFs and SGs in the above-mentioned pathophysiological systems are presented. Discussion is also given on the current challenges and the future perspectives in drug development of these marine glycans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available